Latest News / AZD9291 NewsStream Add Bookmark

Latest articles for AZD9291, as of Sun Apr 20.Want Email Updates? Just use the 'Daily Updates' box on the right!. Below that is a more extensive toolbox that allows you to filter and triage these articles.
Coloured tags show you key topics (e.g. Indications, Drugs, Targets, Companies) also mentioned in the article. Click a tag to see its own NewsStream, or the '' link to create a NewsStream that specifically mentions the two topics together.


 
 
Potential New Drug For Some Patients With TREATMENT-Resistant Lung Cancer

All latest news news from MedicalXpress  (181 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Astrazeneca Ceo Celebrates 1st Anniversary With Promising Lung Cancer Data

FierceBiotech  (201 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
With Promising Results, Astrazeneca Targets Mutated Lung Cancer And Rival ... - Thestreet.Com

Drug Web Reports  (202 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
With Promising Results, Astrazeneca Targets Mutated Lung Cancer And Rival Clovis Drug

TheStreet.com  (202 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Tolerability,Pharmacokinetics&Preliminary Antitumour Activity Of Ascending Doses Of AZD9291 In Patients With Advanced Non Small Cell Lungcancer Who Have Progressed Following Prior Therapy With An Epidermal Growth Factorreceptortyrosinekinaseinhibatoragent

ClinicalTrials.gov Trial Updates Record#NCT01802632 [Sponsor:AstraZene...  (414 days ago)

Clinical Trial: Expand | View [This Window] [New Window]


No More Articles Available


Topic Activity [last 90 days]

Please wait... If the chart does not appear, try updating your browser, ensuring javasript is turned turned on

  Daily Alerts!

 Get Regular Updates By:  Email or RSS

[Need Help With RSS?]
 About This Topic  Data Mining Tools  My Recent Topics  Quick Help

Sponsored Links


Interested in sponsoring our site or advertising with us? Be a part of SciBites growing success. Contact Us Today.



View as RDF